Alerts will be sent to your verified email
Verify Email
REMUS
|
Remus Pharmaceutical
|
Uniphos Enterprises
|
Aeroflex Enterprises
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
38.78 % | 1.42 % | 17.29 % |
|
5yr average Equity Multiplier
|
2.69 | 1.02 | 1.67 |
|
5yr Average Asset Turnover Ratio
|
1.34 | 0.0 | 0.74 |
|
5yr Avg Net Profit Margin
|
12.12 % | 3799.56 % | 16.88 % |
|
Price to Book
|
0.0 | 0.39 | 1.53 |
|
P/E
|
35.82 | 0.0 | 21.32 |
|
5yr Avg Cash Conversion Cycle
|
62.15 Days | -4.45 Days | 100.81 Days |
|
Inventory Days
|
29.3 Days | 33.27 Days | 61.39 Days |
|
Days Receivable
|
196.63 Days | 3.49 Days | 106.58 Days |
|
Days Payable
|
131.74 Days | 110.5 Days | 79.39 Days |
|
5yr Average Interest Coverage Ratio
|
52.6 | 0.53 | 13.6 |
|
5yr Avg ROCE
|
46.86 % | 1.4 % | 22.7 % |
|
5yr Avg Operating Profit Margin
|
14.35 % | -425.44 % | 14.89 % |
|
5 yr average Debt to Equity
|
0.17 | 0.0 | 0.28 |
|
5yr CAGR Net Profit
|
83.69 % | 13.98 % | 43.37 % |
|
5yr Average Return on Assets
|
16.02 % | 1.4 % | 11.06 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.85 % | 73.79 % | 51.59 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.24 % | 0.01 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Remus Pharmaceutical
|
Uniphos Enterprises
|
Aeroflex Enterprises
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|